CellWell record HH-539108
Selected Blood-Accessible Biomarkers in Prostate Cancer Radiotherapy: A PRISMA-ScR Timing-Window Framework Beyond PSA
Miloš Grujić; Barbara Alicja Jereczek‐Fossa; Ivan Jovanović; Marija Živković Radojević; Giulia Marvaso; Katarina Krasić; Katarina Jankovic Jovanovic; Marija Peulic; Federico Mastroleo; Łukasz Kuncman; Vladan Mutavdzic; Milica Mihajlović
Cancers · 2026
In plain language
In this PRISMA-ScR scoping review of 45 studies, no eligible study reported repeated circulating galectin-1/3 kinetics during prostate radiotherapy; funding not stated.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-539108
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.